Wonset Healthcare Pvt Ltd
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Wonride MV 1 Tablet SR is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults.
Tablet SR
Wonride MV 1 Tablet SR is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Wonride MV 1 Tablet SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Wonride MV 1 Tablet SR.
Wonride MV 1 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Wonride MV 1 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Wonride MV 1 Tablet SR is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Wonride MV 1 Tablet SR is a combination medication containing Glimepiride, Metformin, and Voglibose. It is used to manage type 2 diabetes mellitus (DM). This medication aims to improve blood glucose levels in adults when combined with appropriate dietary changes and regular physical activity. Glimepiride helps increase insulin release from the pancreas, while metformin lowers glucose production in the liver and improves insulin sensitivity. Voglibose acts as an alpha-glucosidase inhibitor, reducing postprandial (after meal) glucose levels.
Common side effects associated with Wonride MV 1 Tablet SR include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste perception, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. These are generally mild and manageable.
The use of Wonride MV 1 Tablet SR is contraindicated in patients with known allergies to any of the medication's components or excipients. Individuals with moderate to severe kidney disease, inflammatory bowel disease (IBD), colonic ulcerations, and underlying metabolic acidosis including diabetic ketoacidosis should avoid this medication.
No, consumption of alcohol with Wonride MV 1 Tablet SR is not recommended. Alcohol can lower blood sugar levels and increase the risk of lactic acidosis.
Yes, using Wonride MV 1 Tablet SR may lead to hypoglycemia (low blood sugar). Symptoms of this include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. This risk is amplified when missing meals, consuming alcohol, exercising excessively, or taking other antidiabetic medications alongside Wonride MV 1 Tablet SR. It's essential to monitor blood sugar levels regularly and carry glucose tablets, honey, or fruit juice for immediate remedy.
Store this medication in its original packaging, tightly sealed. Follow the instructions provided on the label or package for storage. Discard unused medication to prevent potential misuse by others. Ensure that this medicine is inaccessible to pets, children, and other individuals.